Loading fund overlap…
8 of 183 unique stocks in common · Jaccard: 4.4%
A weighted portfolio overlap of 7.61% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹7.61 is allocated to the exact same companies at the same relative proportions. The schemes share 8 common holdings.
The largest overlapping asset in their portfolios is Sun Pharmaceutical Industries, which commands a weight of 2.97% in Aditya Birla Sun Life Manufacturing Equity Fund and 13.91% in Back to Index. Holding both schemes increases your concentration in Sun Pharmaceutical Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in Back |
|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 2.97% | 13.91% |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | 1.85% | 1.52% |
| Ajanta PharmaPharmaceuticals & Biotechnology | 1.71% | 0.85% |
| Piramal PharmaPharmaceuticals & Biotechnology | 0.99% | 0.71% |
| Onesource Specialty PharmaPharmaceuticals & Biotechnology | 0.89% | 0.68% |
| Sai Life SciencesPharmaceuticals & Biotechnology | 0.46% | 1.03% |
| Shilpa MedicarePharmaceuticals & Biotechnology | 1.11% | 0.34% |
| Solara Active Pharma SciencesPharmaceuticals & Biotechnology | 0.59% | 0.08% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Apr 2026). Equity holdings only, ISIN-verified. Not investment advice.